Back to top

Analyst Blog

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

Simcere Pharmaceutical Group recently announced that its Board has agreed to a buyout proposal from a conglomerate led by founder Mr. Jinsheng Ren, New Good Management Limited, Assure Ahead Investments Limited and its subsidiaries.

We remind investors that the proposal was initially made in Mar 2013. In response, Simcere’s Board formed a special committee of independent directors to consider the proposal.

Ren founded Simcere in Mar 1995. The conglomerate currently has an approximate 77.6% stake in Simcere.

As per the buyout offer, shareholders of Simcere will receive $4.83 per share or $9.66 per American depositary share (ADS), up from the original offer of $4.78 per share or $9.56 per ADS. We note that each ADS represents two ordinary shares of Simcere. 

The offer price represents a 21.4% premium over the closing price of $7.96 per ADS on Mar 8, 2013.  The transaction is expected to close by 2013 end.

We note that Simcere’s decision to go private comes in the wake of tough business conditions that it has been facing in the last few months. 

Simcere’s second-quarter results were disappointing. Simcere is expected to face challenging market conditions in the remainder of 2013 as well due to pricing pressure from the government. 

Hence, the increased offer price should come as a relief to the shareholders. 

Simcere Pharma currently carries a Zacks Rank #3 (Hold). However, others stocks which look attractive include Biogen Idec Inc.  (BIIB - Analyst Report), Actavis, Inc. (ACT - Analyst Report) and Actelion Ltd. (ALIOF), each with a Zacks Rank #1 (Strong Buy).

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

Learn more

Start for as little as $4.50 per trade.

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
DIXIE GROUP DXYN 15.84 +7.90%
BOFL HOLDING BOFI 85.30 +4.97%
RAMBUS INC RMBS 12.31 +4.41%
VIPSHOP HOLD VIPS 148.73 +4.35%
NETFLIX INC NFLX 345.74 +4.32%